Burning Rock Biotech (BNR) Shares Outstanding (Weighted Average) (2021 - 2023)

Burning Rock Biotech has reported Shares Outstanding (Weighted Average) over the past 3 years, most recently at $11.8 million for Q4 2023.

  • Quarterly results put Shares Outstanding (Weighted Average) at $11.8 million for Q4 2023, down 2.95% from a year ago — trailing twelve months through Dec 2023 was $11.8 million (down 2.95% YoY), and the annual figure for FY2023 was $11.8 million, down 8.38%.
  • Shares Outstanding (Weighted Average) for Q4 2023 was $11.8 million at Burning Rock Biotech, down from $12.2 million in the prior quarter.
  • Over the last five years, Shares Outstanding (Weighted Average) for BNR hit a ceiling of $12.2 million in Q4 2022 and a floor of $2.7 million in Q4 2021.
  • Median Shares Outstanding (Weighted Average) over the past 3 years was $11.8 million (2023), compared with a mean of $8.9 million.
  • Biggest five-year swings in Shares Outstanding (Weighted Average): skyrocketed 349.27% in 2022 and later fell 2.95% in 2023.
  • Burning Rock Biotech's Shares Outstanding (Weighted Average) stood at $2.7 million in 2021, then skyrocketed by 349.27% to $12.2 million in 2022, then fell by 2.95% to $11.8 million in 2023.
  • The last three reported values for Shares Outstanding (Weighted Average) were $11.8 million (Q4 2023), $12.2 million (Q4 2022), and $2.7 million (Q4 2021) per Business Quant data.